Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Express Scripts
Queensland Health
Merck
Citi
Johnson and Johnson
Boehringer Ingelheim
Covington
Julphar

Generated: April 22, 2018

DrugPatentWatch Database Preview

IDARUBICIN HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Idarubicin Hydrochloride patents expire, and when can generic versions of Idarubicin Hydrochloride launch?

Idarubicin Hydrochloride is a drug marketed by Fresenius Kabi Usa, Mylan Labs Ltd, Sandoz, Teva Parenteral, West-ward Pharms Int, and Teva Pharms Usa. and is included in seven NDAs.

The generic ingredient in IDARUBICIN HYDROCHLORIDE is idarubicin hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the idarubicin hydrochloride profile page.
Drug patent expirations by year for IDARUBICIN HYDROCHLORIDE
Pharmacology for IDARUBICIN HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for IDARUBICIN HYDROCHLORIDE
Synonyms for IDARUBICIN HYDROCHLORIDE
(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, hydrochloride
(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside
(1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-A-l-lyxo-hexopyranoside
(1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(7S-cis)-9-Acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxynaphthacene-5,12-dione hydrochloride
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione
(7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione hydrochloride
(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-9-ethanoyl-6,9,11-tris(oxidanyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride
(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
(7S,9S)-9-acetyl-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
(7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione
15158-EP2270008A1
15158-EP2272827A1
15158-EP2275420A1
15158-EP2277879A1
15158-EP2280012A2
15158-EP2281815A1
15158-EP2289892A1
15158-EP2292615A1
15158-EP2292617A1
15158-EP2295055A2
15158-EP2295416A2
15158-EP2295426A1
15158-EP2295427A1
15158-EP2298748A2
15158-EP2298764A1
15158-EP2298765A1
15158-EP2301928A1
15158-EP2301933A1
15158-EP2305640A2
15158-EP2305642A2
15158-EP2305671A1
15158-EP2308833A2
15158-EP2308855A1
15158-EP2311453A1
15158-EP2311808A1
15158-EP2311825A1
15158-EP2311827A1
15158-EP2311829A1
15158-EP2311842A2
15158-EP2316832A1
15158-EP2316833A1
33820-EP2275420A1
33820-EP2295055A2
33820-EP2295416A2
33820-EP2298748A2
33820-EP2298764A1
33820-EP2298765A1
33820-EP2298768A1
33820-EP2305642A2
33820-EP2311453A1
4-Demethoxydaunomycin
4-Demethoxydaunorubicin
4-Demethoxydaunorubicin hydrochloride
4-Demethoxydaunorubicin|||IMI-30|||NSC-256439|||(7S,9S)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
4-Desmethoxydaunorubicin
4-DMD
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-
5,12-Naphthacenedione, 7,8,9,10-tetrahydro-9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,9,11-trihydroxy-, (7S-cis)-
5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7S-cis)-
5,12-Naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxyhydrochloride, (7S-cis)-
57852-57-0
57852-57-0 (HYDROCHLORIDE)
58957-92-9
58957-92-9 (Parent)
5VV3MDU5IE
852I570
957I929
A832088
AB00698511_11
AB00698511-06
AB00698511-08
AB00698511-09
AB00698511-10
AC-5255
AC-9384
AC1L28SA
AC1LCS3T
AC1Q6JJ4
AKOS015895563
AKOS025402118
Ambap57852-57-0
AN-11145
API0002970
API0002971
BCP9000773
BCPP000207
BDBM58490
BRD-K69650333-001-01-1
C-22925
C26H27NO9
C26H27NO9.HCl
CAS-57852-57-0
CC-29462
CCG-100886
CCG-204689
CCRIS 5083
CHEBI:31686
CHEBI:42068
CHEMBL1117
CHEMBL1200976
cid_636362
CPD000466355
CS-1061
D01747
D01XDL
D08062
Daunomycin, 4-demethoxy-
Daunomycin, 4-demethoxy-, hydrochloride
DB01177
demethoxydaunorubicin
DM5
DMDR
DSSTox_CID_27775
DSSTox_GSID_47797
DSSTox_RID_82550
DTXSID0047797
DTXSID7023142
EINECS 260-990-7
EU-0100600
EX-A1148
FT-0621481
GTPL7083
HMS2089D05
HMS3261H22
HY-17381
I 1656
I06-1097
Idamycin
Idamycin (TN)
Idamycin PFS
IDARUBICIN
Idarubicin (hydrochloride)
Idarubicin (INN)
Idarubicin [INN:BAN]
Idarubicin Hcl
Idarubicin Hcl Pfs
Idarubicin hydrochlorid
Idarubicin hydrochloride (JP17/USP)
Idarubicin hydrochloride [USAN:USP:INN]
Idarubicin hydrochloride PFS
Idarubicin hydrochloride, solid
Idarubicin, United States Pharmacopeia (USP) Reference Standard
IDARUBICIN(Hydrochloride form)
Idarubicina
Idarubicina [INN-Spanish]
Idarubicine
Idarubicine [INN-French]
Idarubicinhydrochloride
Idarubicinum
Idarubicinum [INN-Latin]
IMI 30
IMI-30
JVHPTYWUBOQMBP-RVFAQHLVSA-N
KBioSS_002388
KSC-230-185-1
KUC110342C
Lopac0_000600
LP00600
LS-94015
MFCD00866457
MFCD00897212
MLS000759470
MLS001401448
MolPort-006-069-198
MolPort-006-167-730
NC00136
NCGC00093976-01
NCGC00093976-02
NCGC00093976-03
NCGC00093976-04
NCGC00093976-05
NCGC00093976-08
NCGC00261285-01
NSC-256439
PL046679
Q-101407
s1228
SAM001246676
SC-17016
SC-25438
SCHEMBL3750
SCHEMBL4838
SMR000466355
SR-01000075934
SR-01000075934-1
SR-01000075934-5
Tox21_111236
Tox21_111236_1
Tox21_500600
UNII-5VV3MDU5IE
UNII-ZRP63D75JW
W-5198
XDXDZDZNSLXDNA-TZNDIEGXSA-N
Z-3092
Zavedos
Zavedos (TN)
ZINC3920266
ZRP63D75JW

US Patents and Regulatory Information for IDARUBICIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride INJECTABLE;INJECTION 065440-001 Aug 4, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride INJECTABLE;INJECTION 065275-001 Dec 14, 2006 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Parenteral IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride INJECTABLE;INJECTION 065037-003 May 1, 2002 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int IDARUBICIN HYDROCHLORIDE idarubicin hydrochloride INJECTABLE;INJECTION 065288-001 May 15, 2007 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
McKesson
Healthtrust
Fish and Richardson
Cantor Fitzgerald
Farmers Insurance
Daiichi Sankyo
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.